Board Of Directors

David J. McNally

President, Director

See bio in Leadership section.

Charles Federico

Director and Chairman

Charles W. Federico has 46 years of experience in the medical device industry. As a Director of MAKO Surgical Corp. (Nasdaq: MAKO), he served as Chairman, Lead Director, Compensation Committee Chairman, Governance Committee Chairman, and an Audit Committee Member between 2007 – 2013. MAKO, a developer of minimally invasive robotic-enabled techniques for knee surgery, was sold to Stryker in 2013 for $1.65 billion. Prior to that, Mr. Federico served as the President and Chief Executive Officer at Orthofix International N.V. from January 1, 2001 to April 1, 2006. He has also held various management and marketing positions at Orthofix Inc., Smith & Nephew Endoscopy (formerly Dyonics, Inc.), General Foods Corporation, Air Products Corporation, Puritan Bennett Corporation and LSE Corporation and has held board of director positions at Orthofix International, SRI Surgical Express Inc., LENSAR Inc., Salumedica, Active Implants Corporation, Power Medical Interventions Inc. and BioMimetic Therapeutics Inc. In addition, Mr. Federico has served on the Board of Trustees of the Orthopaedic Research and Education Foundation, has served as an Advisory Member and Trustee to the School of Biomedical Engineering at Virginia Tech and Wake Forest Universities and was a founding Trustee and Member of the Board of the American Sports Medicine Institute.

John E. Barker


Mr. Barker is a finance professional with general management experience. Mr. Barker previously acted as the Senior Vice President of Finance, Chief Financial Officer and in other senior executive positions at Zenon Environmental Inc. a Toronto Stock Exchange listed Company, from 2000 to 2006. Mr. Barker currently sits as a director and Chairman of the Audit Committee of Ecosynthetix Inc., a TSX listed Company. Mr Barker is a Fellow of the Chartered Professional Accountants of Canada and holds the FCMA designation. Mr. Barker has been a member of the Titan Board since 2009.

Stephen Randall

Chief Financial Officer, Director

See bio in Leadership section.

John E. Schellhorn


Mr. Schellhorn is a 32-year veteran of the medical technology industry, where he has held various senior management positions in the US, Canada and Asia/Pacific. He is currently President and CEO of Global Kinetics Corporation, a Melbourne, Australia headquartered company commercializing the world’s first objective measurement technology for patients with Parkinson’s Disease.  From 2012 to 2016, he was President and CEO of Monteris Medical Inc., a Canadian neurosurgery company which employed the world’s first MRI compatible robot. From 2010 to 2012 he was Chief Commercialization Officer of BÂRRX Medical, Inc. His other assignments have included CEO of Softscope Medical Technologies and V.P. /GM International, ACMI, Inc. He held various management positions within Boston Scientific, including Director of Sales and Marketing, Asia/Pacific; General Manager, Australia; and Vice President of Sales for the Microvasive Urology division. He earned a B.A, Summa Cum Laude, from Long Island University.   Prior to his commercial career, he served seven years as a U.S. Marine Corps officer and aviator.

error: Content is protected !!